Compare ONC & VICI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONC | VICI |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | Switzerland | United States |
| Employees | 12000 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.4B | 30.7B |
| IPO Year | N/A | 2017 |
| Metric | ONC | VICI |
|---|---|---|
| Price | $301.47 | $26.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $385.10 | $33.75 |
| AVG Volume (30 Days) | 301.7K | ★ 7.6M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 6.29% |
| EPS Growth | N/A | ★ 1.95 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $4,006,116,000.00 |
| Revenue This Year | $723.76 | $4.47 |
| Revenue Next Year | $15.04 | $1.67 |
| P/E Ratio | $614.06 | ★ $31.80 |
| Revenue Growth | N/A | ★ 4.08 |
| 52 Week Low | $249.00 | $26.02 |
| 52 Week High | $385.22 | $34.01 |
| Indicator | ONC | VICI |
|---|---|---|
| Relative Strength Index (RSI) | 60.53 | 39.47 |
| Support Level | $289.57 | N/A |
| Resistance Level | $310.50 | $28.78 |
| Average True Range (ATR) | 7.84 | 0.59 |
| MACD | 4.67 | -0.02 |
| Stochastic Oscillator | 73.54 | 2.74 |
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
VICI Properties Inc is a real estate investment trust based in the United States. It engaged in the business of owning and acquiring gaming, hospitality, wellness, entertainment and leisure destinations, subject to long-term triple net leases. It own nearly 93 experiential assets across a geographically portfolio consisting of nearly 54 gaming properties and nearly 39 other experiential properties across the United States and Canada, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas.